Cargando…
Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand
Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life expe...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357973/ https://www.ncbi.nlm.nih.gov/pubmed/28352616 http://dx.doi.org/10.1016/j.prnil.2017.01.002 |
_version_ | 1782516148333445120 |
---|---|
author | Lojanapiwat, Bannakij Pripatnanont, Choosak Choonhaklai, Vorapot Soontornpun, Surithorn Sriplakich, Supon Leewansangtong, Sunai Santi-ngamkun, Apirak Opanuraks, Julin Kongcharoensombat, Wisoot Na-Songkla, Bhapapak Raksakul, Wiroj Predanon, Chagkrapan |
author_facet | Lojanapiwat, Bannakij Pripatnanont, Choosak Choonhaklai, Vorapot Soontornpun, Surithorn Sriplakich, Supon Leewansangtong, Sunai Santi-ngamkun, Apirak Opanuraks, Julin Kongcharoensombat, Wisoot Na-Songkla, Bhapapak Raksakul, Wiroj Predanon, Chagkrapan |
author_sort | Lojanapiwat, Bannakij |
collection | PubMed |
description | Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life experiences about how to identify CRPC; (2) to choose the appropriate treatment for CRPC patients; (3) to evaluate disease progression using novel inhibitors of the androgen receptor pathway; (4) to identify the frequency of monitoring disease; and (5) to promote rational use of corticosteroids in CRPC patients. This consensus document can provide guidance to other urologists in Thailand to provide appropriate treatment to metastatic CRPC patients in a timely manner. |
format | Online Article Text |
id | pubmed-5357973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Asian Pacific Prostate Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-53579732017-03-28 Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand Lojanapiwat, Bannakij Pripatnanont, Choosak Choonhaklai, Vorapot Soontornpun, Surithorn Sriplakich, Supon Leewansangtong, Sunai Santi-ngamkun, Apirak Opanuraks, Julin Kongcharoensombat, Wisoot Na-Songkla, Bhapapak Raksakul, Wiroj Predanon, Chagkrapan Prostate Int Review Article Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life experiences about how to identify CRPC; (2) to choose the appropriate treatment for CRPC patients; (3) to evaluate disease progression using novel inhibitors of the androgen receptor pathway; (4) to identify the frequency of monitoring disease; and (5) to promote rational use of corticosteroids in CRPC patients. This consensus document can provide guidance to other urologists in Thailand to provide appropriate treatment to metastatic CRPC patients in a timely manner. Asian Pacific Prostate Society 2017-03 2017-01-11 /pmc/articles/PMC5357973/ /pubmed/28352616 http://dx.doi.org/10.1016/j.prnil.2017.01.002 Text en © 2017 Asian Pacific Prostate Society, Published by Elsevier Korea LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Lojanapiwat, Bannakij Pripatnanont, Choosak Choonhaklai, Vorapot Soontornpun, Surithorn Sriplakich, Supon Leewansangtong, Sunai Santi-ngamkun, Apirak Opanuraks, Julin Kongcharoensombat, Wisoot Na-Songkla, Bhapapak Raksakul, Wiroj Predanon, Chagkrapan Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand |
title | Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand |
title_full | Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand |
title_fullStr | Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand |
title_full_unstemmed | Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand |
title_short | Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand |
title_sort | management of metastatic castration-resistant prostate cancer: insights from urology experts in thailand |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357973/ https://www.ncbi.nlm.nih.gov/pubmed/28352616 http://dx.doi.org/10.1016/j.prnil.2017.01.002 |
work_keys_str_mv | AT lojanapiwatbannakij managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT pripatnanontchoosak managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT choonhaklaivorapot managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT soontornpunsurithorn managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT sriplakichsupon managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT leewansangtongsunai managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT santingamkunapirak managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT opanuraksjulin managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT kongcharoensombatwisoot managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT nasongklabhapapak managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT raksakulwiroj managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand AT predanonchagkrapan managementofmetastaticcastrationresistantprostatecancerinsightsfromurologyexpertsinthailand |